We are live on
!
Find out more
TM
Tiger Management Portfolio holdings
AUM
$22.8M
1-Year Est. Return
0.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
+0.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$552M
AUM Growth
+$128M
(+30%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
21.94%
Top 10 Holdings %
Top 10 Hldgs %
60.68%
Holding
42
New
8
Increased
15
Reduced
5
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$25.4M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$22.2M |
| 3 |
Autodesk
ADSK
|
+$21M |
| 4 |
Apple
AAPL
|
+$19.4M |
| 5 |
Take-Two Interactive
TTWO
|
+$18.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$21.6M |
| 2 |
CELG
Celgene Corp
CELG
|
+$7.82M |
| 3 |
Ambev
ABEV
|
+$731K |
| 4 |
MacroGenics
MGNX
|
+$664K |
| 5 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$487K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 20.35% |
| 2 | Technology | 20.31% |
| 3 | Healthcare | 17.65% |
| 4 | Consumer Discretionary | 11.77% |
| 5 | Financials | 11.63% |
Similar funds
CMG
SRCM
A
KLM
OCM
LC
PFG
ICP
Tiger Management's Q4 2016 Portfolio in Review
As of Q4 2016, Tiger Management held 42 positions worth $552M, up 30% from $423M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Tiger Management deployed $121M of net new capital in Q4 2016, opening 8 new positions and adding to 15 existing holdings. Its largest new stake was Bank of America: 1,318,300 shares worth $29.1M.
By sector, the portfolio is most concentrated in Communication Services at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Celgene Corp, an estimated $7.82M trimmed.
- Tiger Management's largest Q4 2016 buy was Bank of America: 1,318,300 shares worth $29.1M.
- Tiger Management added most to Meta Platforms (Facebook) in Q4 2016, an estimated $10.6M increase.
- Tiger Management's biggest Q4 2016 reduction was Celgene Corp, cutting an estimated $7.82M.
- Tiger Management fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $21.6M.
- Tiger Management's ten largest holdings make up 61% of its $552M portfolio in Q4 2016.
- Tiger Management opened 8 new positions and closed 2 in Q4 2016.
- Tiger Management's portfolio value rose 30% quarter-over-quarter to $552M.
Based on Tiger Management's 13F filing for Q4 2016, filed 14 Feb 2017.